Head-to-head comparison
Fitish vs REMEVi
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Oral-capable, LegitScript-verified, and nationwide — trust signals are strong, but pricing sits mid-to-high.
$219/mo sema · $339/mo tirz
Marked down on: Higher pricing than the value leaders
FDAWarning letter issued to FITISH in June 2026. See the FDA warning-letter database.
Desk Score
A flat $219 a month for semaglutide and $319 for tirzepatide at every dose, lower on 12- and 24-week plans, with four named pharmacies and the whole program in English or Spanish.
$219/mo sema · $319/mo tirz · Verified August 2026
Marked down on: The flat rate is a higher entry price than teaser-led competitors
Fitish and REMEVi land level on the Desk Score at 86/100 — too close to call. The right choice comes down to which trade-offs fit your situation.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Fitish
86/100
B
REMEVi
86/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Fitish | REMEVi |
|---|---|---|
| Semaglutide | $219/mo$219/mo | $219/mo$219/mo month-to-month; $189/mo on a 12-week plan; $179/mo on a 24-week plan; same price at every dose; oral tablet $349/mo month-to-month or $309/mo on a 12-week plan |
| Tirzepatide | $339/mo$339/mo | $319/mo$319/mo month-to-month; $249/mo on a 12-week plan; $229/mo on a 24-week plan; same price at every dose; compounded injectable |
| Coverage | All 50 states | All 50 states and DC |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | People who prioritize a verified pharmacy and oral options over finding the lowest rate. | Someone who wants one price that never climbs with the dose — or a Spanish-speaking patient who wants the intake, portal and care team in their own language. |
| Desk Score | 86/100B | 86/100B |
The verdict
Too close to callFitish and REMEVi land level on the Desk Score at 86/100 — too close to call. The right choice comes down to which trade-offs fit your situation.
Choose Fitish if…
People who prioritize a verified pharmacy and oral options over finding the lowest rate.
$219/mo sema · $339/mo tirz · All 50 states
FDAWarning letter issued to FITISH in June 2026. See the FDA warning-letter database.
Choose REMEVi if…
Someone who wants one price that never climbs with the dose — or a Spanish-speaking patient who wants the intake, portal and care team in their own language.
$219/mo sema · $319/mo tirz · All 50 states and DC
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Fitish · REMEVi.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Fitish
- CoreAge Rx vs REMEVi
- Curex vs Fitish
- Curex vs REMEVi
- BetterMe Rx vs Fitish
- BetterMe Rx vs REMEVi
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.